1. Home
  2. IMAB vs INVE Comparison

IMAB vs INVE Comparison

Compare IMAB & INVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • INVE
  • Stock Information
  • Founded
  • IMAB 2014
  • INVE 1990
  • Country
  • IMAB United States
  • INVE United States
  • Employees
  • IMAB N/A
  • INVE N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • INVE Computer peripheral equipment
  • Sector
  • IMAB Health Care
  • INVE Technology
  • Exchange
  • IMAB Nasdaq
  • INVE Nasdaq
  • Market Cap
  • IMAB 79.9M
  • INVE 86.5M
  • IPO Year
  • IMAB 2020
  • INVE 1997
  • Fundamental
  • Price
  • IMAB $0.95
  • INVE $3.51
  • Analyst Decision
  • IMAB Strong Buy
  • INVE Strong Buy
  • Analyst Count
  • IMAB 3
  • INVE 2
  • Target Price
  • IMAB $8.00
  • INVE $7.25
  • AVG Volume (30 Days)
  • IMAB 289.3K
  • INVE 34.6K
  • Earning Date
  • IMAB 03-13-2025
  • INVE 03-11-2025
  • Dividend Yield
  • IMAB N/A
  • INVE N/A
  • EPS Growth
  • IMAB N/A
  • INVE N/A
  • EPS
  • IMAB N/A
  • INVE 3.10
  • Revenue
  • IMAB $3,313,984.00
  • INVE $104,217,000.00
  • Revenue This Year
  • IMAB N/A
  • INVE N/A
  • Revenue Next Year
  • IMAB N/A
  • INVE N/A
  • P/E Ratio
  • IMAB N/A
  • INVE $1.13
  • Revenue Growth
  • IMAB N/A
  • INVE 70.57
  • 52 Week Low
  • IMAB $0.84
  • INVE $2.95
  • 52 Week High
  • IMAB $2.00
  • INVE $9.24
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 43.17
  • INVE 44.12
  • Support Level
  • IMAB $0.95
  • INVE $3.50
  • Resistance Level
  • IMAB $1.04
  • INVE $3.67
  • Average True Range (ATR)
  • IMAB 0.06
  • INVE 0.19
  • MACD
  • IMAB -0.01
  • INVE 0.00
  • Stochastic Oscillator
  • IMAB 10.53
  • INVE 27.91

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About INVE Identiv Inc.

Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has two reportable segments namely the Premises segment which includes solutions to address the premises security market for government and enterprise, including access control, video surveillance, analytics, customer experience, and other applications. Its Identity segment includes products and solutions enabling secure access to information serving the logical access and cyber security market and protecting assets and objects in the IoT with RFID. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific. The company derives the majority of revenue from the Identity segment.

Share on Social Networks: